CLINICAL_TRIALS
research
· 2025-03-20
Clinical Trial Update: Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer [Phase 3]
Summary
This entry describes a Phase 3 clinical trial comparing salvage radiotherapy with individualized PSMA PET/CT–targeted treatment for relapsing prostate cancer, c…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Stefan Carlsson | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING